Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epigenetic modification of m6A regulator proteins in cancer.
Wang Y, Wang Y, Patel H, Chen J, Wang J, Chen ZS, Wang H. Wang Y, et al. Among authors: chen j, chen zs. Mol Cancer. 2023 Jun 30;22(1):102. doi: 10.1186/s12943-023-01810-1. Mol Cancer. 2023. PMID: 37391814 Free PMC article. Review.
Darovasertib, a novel treatment for metastatic uveal melanoma.
Cao L, Chen S, Sun R, Ashby CR Jr, Wei L, Huang Z, Chen ZS. Cao L, et al. Among authors: chen s, chen zs. Front Pharmacol. 2023 Jul 28;14:1232787. doi: 10.3389/fphar.2023.1232787. eCollection 2023. Front Pharmacol. 2023. PMID: 37576814 Free PMC article. Review.
Nivolumab and relatlimab for the treatment of melanoma.
Chen XY, Li YD, Xie Y, Cao LQ, Ashby CR Jr, Zhao H, Chen ZS. Chen XY, et al. Among authors: chen zs. Drugs Today (Barc). 2023 Feb;59(2):91-104. doi: 10.1358/dot.2023.59.2.3509756. Drugs Today (Barc). 2023. PMID: 36811409 Review.
Cancer vaccines in focus: The next frontier in immuno-oncology.
Xie Y, Cao LQ, Yang H, Wurpel J, Chen ZS. Xie Y, et al. Among authors: chen zs. Cancer Lett. 2024 Dec 9;611:217390. doi: 10.1016/j.canlet.2024.217390. Online ahead of print. Cancer Lett. 2024. PMID: 39662677 No abstract available.
New opportunities for RGD-engineered metal nanoparticles in cancer.
Qin W, Chandra J, Abourehab MAS, Gupta N, Chen ZS, Kesharwani P, Cao HL. Qin W, et al. Among authors: chen zs. Mol Cancer. 2023 May 25;22(1):87. doi: 10.1186/s12943-023-01784-0. Mol Cancer. 2023. PMID: 37226188 Free PMC article. Review.
883 results